Antibody response to hepatitis B vaccination in hemodialytic patients

M Sharifi; M Talebi Taher; M Sadeghi

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Support Contact Us

Authors Guide Submit Manuscript

Antibody response to hepatitis B vaccination in hemodialytic patients

Author(s):

M Sharifi,

M Talebi Taher^,*,

M Sadeghi

Journal of Inflammatory Diseases:Vol. 7, issue 1; 47-52

Article type:Research Article

How to Cite:M SharifiM Talebi TaherM SadeghiAntibody response to hepatitis B vaccination in hemodialytic patients.J Inflamm Dis.7(1):e154924.

Abstract

Background: Immune deficiency in hemodialytic and uremic patients decreases antibody response after hepatitis B (HB) vaccination. Acceptable response among these patients is an antibody level above 100 mIU/ml. Objective: To determine antibody response in hemodialytic patients after hepatitis B vaccination. Methods: A cross sectional descriptive study with census sampling was implemented on hemodialytic patients in Bou-Ali Sina teaching hospital of Qazvin in 2000. Eliminiating HBsAg positive and unvaccinated patients, final population was reduced from 70 to 63. Serum samples were tested by ELISA. Findings: Antibody level in 16 patients (25.4%) was undetectable and in overall 37 patients (58.7%) there was no protective antibody level (100 mIU/ml) despite vaccination. Response in female was 51.5% and in male was 30%. Conclusion: With regard to the risk of hepatitis B, completion of vaccination and quantitative test to determine the antibody response for hemodialytic patients is necessary.

Keywords

comments